Search Results 121-130 of 14919 for Tamoxifen

  1. Recurrent breast cancer

    Treatment adherence and its impact on disease-free survival in the Breast International Group I-98 trial of tamoxifen and letrozole, alone and in sequence.

  2. Medical Research & Education - Mayo Clinic News Network

    Women's Wellness: Do hot flashes indicate heart disease? Dana Sparks. February 1, 2018. New international practice guidelines for tamoxifen treatment based on ...

  3. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  4. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  5. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  6. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  7. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  8. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  9. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.

  10. Precision medicine for breast cancer - Doctors & Departments - Mayo Clinic

    First-in-human phase I study of the tamoxifen metabolite z-endoxifen in women with endocrine-refractory metastatic breast cancer. Journal of Clinical Oncology.